European Aids Treatment Group eV

Where the EU money came from

Funding by EU programme. Amounts are European Aids Treatment Group eV's own share of each project, not the project's full budget.

Projects

15 EU-funded projects, newest first. Each links to the official record.

• VIROMARKERSPartner

  Virus related biomarkers to improve management of chronic conditions

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €50ktheir share
• READIPartner

  REpresentative Clinical Research - ADvancing Inclusivity in Europe

  Horizon Europe · 2025–2030 · Project on CORDIS ↗

  €582ktheir share
• COREPartner

  CORE - Community Response to End Inequalities

  EU4Health Programme (EU4H) · 2023–2025 · Project on the EU portal ↗

  €162ktheir share
• RBDCOVPartner

  RBD Dimer recombinant protein vaccine against SARSCoV2

  Horizon Europe · 2021–2025 · Project on CORDIS ↗

  €609ktheir share
• EATRIS-PlusAssociated partner

  Consolidating the capacities of EATRIS-ERIC for Personalised Medicine

  Horizon 2020 · 2020–2023 · Project on CORDIS ↗
• EU-PEARLAssociated partner

  EU Patient- cEntric clinicAl tRial pLatform

  Horizon 2020 · 2019–2023 · Project on CORDIS ↗
• EFOEUPATIPartner

  Ensuring the future of EUPATI beyond 2020

  Horizon 2020 · 2018–2020 · Project on CORDIS ↗

  €31ktheir share
• PARADIGMPartner

  Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

  Horizon 2020 · 2018–2020 · Project on CORDIS ↗

  €382ktheir share
• HIVACARPartner

  Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection

  Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  €150ktheir share
• EHVAPartner

  European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

  Horizon 2020 · 2016–2023 · Project on CORDIS ↗

  €50ktheir share
• EmERGEPartner

  Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised care

  Horizon 2020 · 2015–2020 · Project on CORDIS ↗

  €483ktheir share
• ECRANPartner

  European Communication on Research Awareness Needs

  FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

  €26ktheir share
• EUPATIPartner

  European Patients' Academy on Therapeutic Innovation

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  €289ktheir share
• CHAARMPartner

  Combined Highly Active Anti-retroviral Microbicides

  FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

  €33ktheir share
• EUCO-NETPartner

  European network for global cooperation in the field of AIDS & TB

  FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

  €64ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerSpain · 5 shared projects
• Forum des Patients EuropeensBelgium · 5 shared projects
• Novo Nordisk A/SDenmark · 5 shared projects
• Novartis Pharma AGSwitzerland · 5 shared projects
• Pfizer LimitedUnited Kingdom · 5 shared projects
• Instituut Voor Tropische GeneeskundeBelgium · 4 shared projects
• Janssen Pharmaceutica NVBelgium · 4 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 4 shared projects
• Hospital Clinic de BarcelonaSpain · 4 shared projects
• Ucb BiopharmaBelgium · 4 shared projects
• Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 3 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 3 shared projects
• Karolinska InstitutetSweden · 3 shared projects
• Istituto Superiore di SanitaItaly · 3 shared projects
• Klinikum der Universitaet zu KoelnGermany · 3 shared projects
• Zabala Innovation Consulting SASpain · 3 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• HIV
• business models
• coronaviruses
• databases
• drug discovery
• ecosystems
• governance
• health economics
• mobile phones
• mortality
• pharmaceutical drugs
• proteins
• public health
• stem cells